SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kumaka Industries not to invest in Pinnacle Therapeutics

01 Aug 2016 Evaluate

Kumaka Industries has decided not to go for investment in Pinnacle Therapeutics due to non availability of requisite finance. Earlier on July 06, 2015, the company decided to make investment of Rs 1 lakh in Equity shares of Pinnacle Therapeutics, so to make it wholly owned subsidiary of the Company.

The company is a leading manufacturer of pharmaceutical products. The company currently has its own manufacturing facility in GIDC Ankleshwar, Gujarat(India) to manufacturers Corticosteroids and its Salts. Over a period of time the company has understood the needs of its customers.

Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×